Lenvatinib promotes antitumor immunity by enhancing the tumor infiltration and activation of NK cells.
Qing Zhang(South China University of Technology), Junnian Zheng(Xuzhou Medical College), Xiaoge Gao(Xuzhou Medical College), Mengmeng Lü(Xuzhou Medical College), Jiage Ding(Xuzhou Medical College), Yangna Miao(Xuzhou Medical College), Hongyan Liu(Wenzhou Medical University), Shishuo Sun(Xuzhou Medical College), Huizhong Li(Jiangsu University), Hanhan Wang(Xuzhou Medical College)
PubMed
January 1, 2019
Cited by 44
Related Papers
Decorin is a pivotal effector in the extracellular matrix and tumour microenvironment
|Oncotarget|2018|217
DNA damage response – A double-edged sword in cancer prevention and cancer therapy
|Cancer Letters|2014|189
Combination Therapy with EpCAM-CAR-NK-92 Cells and Regorafenib against Human Colorectal Cancer Models
|Journal of Immunology Research|2018|152
HAb18G/CD147 Functions in Invasion and Metastasis of Hepatocellular Carcinoma
|Molecular Cancer Research|2007|148
The next-generation DNA vaccine platforms and delivery systems: advances, challenges and prospects
|Frontiers in Immunology|2024|136